Status:
COMPLETED
Retrospective Evaluation of the Radiographic Efficacy of Conventional and Biologic Treatment
Lead Sponsor:
Pfizer
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Brief Summary
This study involves review and analysis of disease activity in patients with rheumatoid arthritis who where treated with either conventional DMARDs (Disease Modifying Antirheumatic Drugs) or Biologics...
Eligibility Criteria
Inclusion
- Secure diagnosis of rheumatoid arthritis
- Older than 18 years
- Two consecutive plain radiographs of the hands and feet with a time interval of 12 to 36 months are available. The radiographs are recorded 2003 or later and are in accordance with a defined X-ray protocol.
Exclusion
- \- Patients who receive Anakinra, Rituximab or Abatacept
Key Trial Info
Start Date :
August 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2010
Estimated Enrollment :
156 Patients enrolled
Trial Details
Trial ID
NCT00929357
Start Date
August 1 2009
End Date
June 1 2010
Last Update
August 10 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Schmittingheide 20-32, Munster, Denmark, 48155